Morgan Stanley’s ContraFect Corporation CFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-119
| Closed | -$68 | – | 8078 |
|
|
2023
Q3 | $68 | Hold |
119
| – | – | ﹤0.01% | 7472 |
|
|
2023
Q2 | $179 | Hold |
119
| – | – | ﹤0.01% | 7456 |
|
|
2023
Q1 | $218 | Sell |
119
-394
| -77% | -$1.85K | ﹤0.01% | 7510 |
|
|
2022
Q4 | $3.94K | Buy |
513
+400
| +354% | +$4.63K | ﹤0.01% | 7210 |
|
|
2022
Q3 | $1K | Sell |
113
-130
| -53% | -$6.57K | ﹤0.01% | 7666 |
|
|
2022
Q2 | $59K | Sell |
243
-125
| -34% | -$35.3K | ﹤0.01% | 6545 |
|
|
2022
Q1 | $107K | Sell |
368
-1
| -0.3% | -$243 | ﹤0.01% | 6266 |
|
|
2021
Q4 | $78K | Sell |
369
-9
| -2% | -$2.47K | ﹤0.01% | 6578 |
|
|
2021
Q3 | $122K | Sell |
378
-160
| -30% | -$49.8K | ﹤0.01% | 6261 |
|
|
2021
Q2 | $190K | Buy |
538
+51
| +10% | +$16.7K | ﹤0.01% | 6045 |
|
|
2021
Q1 | $188K | Sell |
487
-264
| -35% | -$114K | ﹤0.01% | 5691 |
|
|
2020
Q4 | $303K | Buy |
751
+160
| +27% | +$69.2K | ﹤0.01% | 5367 |
|
|
2020
Q3 | $250K | Sell |
591
-82
| -12% | -$37.2K | ﹤0.01% | 4990 |
|
|
2020
Q2 | $344K | Buy |
673
+55
| +9% | +$27K | ﹤0.01% | 4797 |
|
|
2020
Q1 | $285K | Buy |
+618
| New | +$422K | ﹤0.01% | 4707 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6880 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6859 |
|
|
2019
Q1 | – | Sell |
-7
| Closed | -$3.03K | – | 6807 |
|
|
2018
Q4 | $9K | Buy |
7
+4
| +133% | +$6.35K | ﹤0.01% | 6198 |
|
|
2018
Q3 | $5K | Buy |
+3
| New | +$4.96K | ﹤0.01% | 6466 |
|
|
2018
Q2 | – | Sell |
-56
| Closed | -$82.5K | – | 6630 |
|
|
2018
Q1 | $73K | Buy |
56
+53
| +1,767% | +$65.4K | ﹤0.01% | 5795 |
|
|
2017
Q4 | $3K | Sell |
3
-1
| -25% | -$827 | ﹤0.01% | 6421 |
|
|
2017
Q3 | $3K | Buy |
4
+2
| +100% | +$1.89K | ﹤0.01% | 6380 |
|
|
2017
Q2 | $2K | Hold |
2
| – | – | ﹤0.01% | 6477 |
|
|
2017
Q1 | $3K | Hold |
2
| – | – | ﹤0.01% | 6435 |
|
|
2016
Q4 | $3K | Hold |
2
| – | – | ﹤0.01% | 6358 |
|
|
2016
Q3 | $4K | Sell |
2
-1
| -33% | -$1.96K | ﹤0.01% | 6290 |
|
|
2016
Q2 | $7K | Hold |
3
| – | – | ﹤0.01% | 6161 |
|
|
2016
Q1 | $9K | Hold |
3
| – | – | ﹤0.01% | 6163 |
|
|
2015
Q4 | $12K | Sell |
3
-3
| -50% | -$10K | ﹤0.01% | 6193 |
|
|
2015
Q3 | $19K | Buy |
6
+5
| +500% | +$19.7K | ﹤0.01% | 6071 |
|
|
2015
Q2 | $5K | Sell |
1
-16
| -94% | -$64.9K | ﹤0.01% | 6426 |
|
|
2015
Q1 | $70K | Buy |
17
+13
| +325% | +$47.2K | ﹤0.01% | 5671 |
|
|
2014
Q4 | $12K | Buy |
4
+1
| +33% | +$2.51K | ﹤0.01% | 6179 |
|
|
2014
Q3 | $10K | Buy |
+3
| New | +$10K | ﹤0.01% | 6201 |
|
Other funds holding CFRX
Morgan Stanley's CFRX Position: Q4 2023 in Review
Morgan Stanley sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 119 shares — an estimated $68 sold.
Morgan Stanley first reported a position in CFRX in Q3 2014 and held it in 32 quarters. The position peaked at $344K in Q2 2020. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.
- Morgan Stanley reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
- Morgan Stanley sold 119 ContraFect Corporation shares in Q4 2023, an estimated $68.
- Morgan Stanley first reported a position in ContraFect Corporation in Q3 2014 and held it in 32 quarters.
- Morgan Stanley's ContraFect Corporation position peaked at $344K in Q2 2020.
- 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.